After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Founded in 2018, Defiance is at the forefront of ETF innovation. Defiance is a leading ETF issuer specializing in thematic, ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $34.71, marking a +0.7% move from the previous day.

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...

Changes are afoot in the teledermatology space. As Hims & Hers shutters Apostrophe, the teledermatology specialist it ...

Apostrophe is being shut down to "simplify its (company's) dermatology products and operations into one seamless experience," ...

A holistic approach emphasizes lifestyle choices, nutrition, exercise, stress management, medications where appropriate, and ...

Private Advisor Group LLC acquired a new stake in Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) in the 4th quarter, ...

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...